Clinical Research Directory
Browse clinical research sites, groups, and studies.
Multi-omics Merge for Ensemble Subtyping for Atherosclerotic Cardiovascular Disease
Sponsor: Henan Province Clinical Research Center for Cardiovascular Diseases
Summary
The current biological issues driving the evolutionary progression of coronary artery disease are in focus: at this stage, the biological evidence for them is scarce and small in scale, with the exception of metabolomics and microbiomics. Issues such as histologic mapping of coronary atherosclerosis deterioration remain to be corroborated by more clinical and basic evidence! By analyzing the clinical data and multi-omics data of patients with coronary heart disease, investigators will explore the related risk factors and establish molecular subtypes and prognostic prediction models for individualized prediction of coronary heart disease risk, in order to guide the clinical screening of high-risk groups of coronary heart disease and formulate more targeted intervention countermeasures.
Official title: Multi-omics Merge for Ensemble Subtyping for Atherosclerotic Cardiovascular Disease and Related Mechanism Study
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2024-09-01
Completion Date
2026-03-01
Last Updated
2024-06-25
Healthy Volunteers
No
Conditions
Locations (1)
Department of Cardiology, The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China